Hilel Lewis1. 1. Cole Eye Institute, Division of Ophthalmology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. leish@ccf.org
Abstract
PURPOSE: To review the degenerative diseases of the peripheral retina in relationship with the risk to develop a rhegmatogenous retinal detachment and to present recommendations for use in eyes at increased risk of developing a retinal detachment. DESIGN: Focused literature review and author's clinical experience. RESULTS: Retinal degenerations are common lesions involving the peripheral retina, and most of them are clinically insignificant. Lattice degeneration, degenerative retinoschisis, cystic retinal tufts, and, rarely, zonular traction tufts, can result in a rhegmatogenous retinal detachment. Therefore, these lesions have been considered for prophylactic therapy; however, adequate studies have not been performed to date. CONCLUSIONS: Well-designed, prospective, randomized clinical studies are necessary to determine the benefit-risk ratio of prophylactic treatment. In the meantime, the evidence available suggests that most of the peripheral retinal degenerations should not be treated except in rare, high-risk situations.
PURPOSE: To review the degenerative diseases of the peripheral retina in relationship with the risk to develop a rhegmatogenous retinal detachment and to present recommendations for use in eyes at increased risk of developing a retinal detachment. DESIGN: Focused literature review and author's clinical experience. RESULTS:Retinal degenerations are common lesions involving the peripheral retina, and most of them are clinically insignificant. Lattice degeneration, degenerative retinoschisis, cystic retinal tufts, and, rarely, zonular traction tufts, can result in a rhegmatogenous retinal detachment. Therefore, these lesions have been considered for prophylactic therapy; however, adequate studies have not been performed to date. CONCLUSIONS: Well-designed, prospective, randomized clinical studies are necessary to determine the benefit-risk ratio of prophylactic treatment. In the meantime, the evidence available suggests that most of the peripheral retinal degenerations should not be treated except in rare, high-risk situations.
Authors: M Bianco; A S Vaiano; F Colella; F Coccimiglio; M Moscetti; V Palmieri; F Focosi; P Zeppilli; P F Vinger Journal: Br J Sports Med Date: 2005-02 Impact factor: 13.800
Authors: M Bianco; A Pannozzo; C Fabbricatore; N Sanna; M Moscetti; V Palmieri; P Zeppilli Journal: Br J Sports Med Date: 2005-08 Impact factor: 13.800
Authors: Wei-Chi Wu; Chi-Chun Lai; Jia-Hau Liu; Tanuja Singh; Lien-Ming Li; Willy J Peumans; Els J M Van Damme; Albert M Wu Journal: Neurochem Res Date: 2006-05-23 Impact factor: 3.996
Authors: Karl Thomas Boden; Kai Januschowski; Peter Szurman; Anna-Maria Seuthe; Annekatrin Rickmann; Berthold Seitz; Mohammad Alsharairi; Stephan Leers; Philip Wakili Journal: BMJ Open Ophthalmol Date: 2021-03-08
Authors: Tien Y Wong; Kyoko Ohno-Matsui; Nicolas Leveziel; Frank G Holz; Timothy Y Lai; Hyeong Gon Yu; Paolo Lanzetta; Youxin Chen; Adnan Tufail Journal: Br J Ophthalmol Date: 2014-07-01 Impact factor: 4.638